标题
Privileged scaffolds in lead generation
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 10, Issue 7, Pages 781-790
出版商
Informa Healthcare
发表日期
2015-05-11
DOI
10.1517/17460441.2015.1041496
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hot spot-based design of small-molecule inhibitors for protein–protein interactions
- (2014) Wenxing Guo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- β-Lactam Estrogen Receptor Antagonists and a Dual-Targeting Estrogen Receptor/Tubulin Ligand
- (2014) Niamh M. O’Boyle et al. JOURNAL OF MEDICINAL CHEMISTRY
- The discovery of first-in-class drugs: origins and evolution
- (2014) Jörg Eder et al. NATURE REVIEWS DRUG DISCOVERY
- Is there new hope for therapeutic matrix metalloproteinase inhibition?
- (2014) Roosmarijn E. Vandenbroucke et al. NATURE REVIEWS DRUG DISCOVERY
- Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
- (2013) Qingsong Liu et al. CHEMISTRY & BIOLOGY
- Metallocarboxypeptidases and their Inhibitors: Recent Developments in Biomedically Relevant Protein and Organic Ligands
- (2013) D. Fernandez et al. CURRENT MEDICINAL CHEMISTRY
- Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors
- (2013) Rand M. Miller et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Recent Syntheses of 1,2,3,4-Tetrahydroquinolines, 2,3-Dihydro-4(1H)-quinolinones and 4(1H)-Quinolinones using Domino Reactions
- (2013) Baskar Nammalwar et al. MOLECULES
- Abbott Physicochemical Tiering (APT)—A unified approach to HTS triage
- (2012) Philip B. Cox et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Boron Containing Compounds as Protease Inhibitors
- (2012) Reem Smoum et al. CHEMICAL REVIEWS
- Privileged Structures - Dream or Reality: Preferential Organization of Azanaphthalene Scaffold
- (2012) J. Polanski et al. CURRENT MEDICINAL CHEMISTRY
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs
- (2011) M. Amélia Santos et al. COORDINATION CHEMISTRY REVIEWS
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- The resurgence of covalent drugs
- (2011) Juswinder Singh et al. NATURE REVIEWS DRUG DISCOVERY
- Structural conservation of druggable hot spots in protein-protein interfaces
- (2011) D. Kozakov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery
- (2010) Grzegorz M. Popowicz et al. CELL CYCLE
- Privileged scaffolds for library design and drug discovery
- (2010) Matthew E Welsch et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Strategies for discovering and derisking covalent, irreversible enzyme inhibitors
- (2010) Douglas S Johnson et al. Future Medicinal Chemistry
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug-Target Networks
- (2010) Ingo Vogt et al. Molecular Informatics
- Kinase-targeted libraries: The design and synthesis of novel, potent, and selective kinase inhibitors
- (2009) Irini Akritopoulou-Zanze et al. DRUG DISCOVERY TODAY
- Covalent Modifiers: An Orthogonal Approach to Drug Design
- (2009) Michele H. Potashman et al. JOURNAL OF MEDICINAL CHEMISTRY
- The topology of drug–target interaction networks: implicit dependence on drug properties and target families
- (2009) Jordi Mestres et al. Molecular BioSystems
- Energetic determinants of protein binding specificity: Insights into protein interaction networks
- (2009) Pablo Carbonell et al. PROTEOMICS
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started